Document Detail


Synthesis of valproyl-2-pyrrolidinone and its evaluation as a cognitive drug with the ability to modulate acidic amino acids in the brain.
MedLine Citation:
PMID:  1971306     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A new pyrrolidinone derivative, valproyl-2-pyrrolidinone (VP), was synthesized, followed by evaluation as a cognitive drug. VP gave rise to a significant protective effect against cerebral anoxia together with a potent prolongation of latency time for the reversal of scopolamine induced transient disruption of the memory of a passive avoidance response in rats. The quantitative experiment using HPLC demonstrated a significant reduction of hippocampal aspartate (Asp) and glutamate (Glu) following the intraperitoneal administration of VP at a dose of 300 mg/kg.
Authors:
C Miyazaki; K Matsuyama; M Ichikawa; S Goto; J Yamamoto
Related Documents :
21187946 - Sustained-release progesterone nanosuspension following intramuscular injection in ovar...
24719876 - Nitric oxide and superoxide anion balance in rats exposed to chronic and long term inte...
24396406 - Effects of glutamine on oxidative stress and nuclear factor-κb expression in the livers...
7174066 - Effect of physostigmine and atropine on the single-trial passive avoidance response in ...
6476126 - Effects of saline infusion on titratable acid generation and ammonia secretion.
22330706 - Administration of substances to laboratory animals: equipment considerations, vehicle s...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of pharmacobio-dynamics     Volume:  13     ISSN:  0386-846X     ISO Abbreviation:  J. Pharmacobio-dyn.     Publication Date:  1990 Jan 
Date Detail:
Created Date:  1990-06-28     Completed Date:  1990-06-28     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7901854     Medline TA:  J Pharmacobiodyn     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  70-5     Citation Subset:  IM    
Affiliation:
Department of Hospital Pharmacy, Nagasaki University Hospital, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Animals
Aspartic Acid / metabolism*
Behavior, Animal / drug effects
Brain / metabolism*
Cognition / drug effects*
Glutamates / metabolism*
Glutamic Acid
Hippocampus / metabolism
Male
Pantothenic Acid / analogs & derivatives,  pharmacology
Pyrrolidinones / administration & dosage,  chemical synthesis,  pharmacology*
Rats
Rats, Inbred Strains
gamma-Aminobutyric Acid / analogs & derivatives,  pharmacology
Chemical
Reg. No./Substance:
0/Glutamates; 0/Pyrrolidinones; 120425-64-1/valproyl-2-pyrrolidinone; 1977-33-9/pantogab; 56-12-2/gamma-Aminobutyric Acid; 56-84-8/Aspartic Acid; 56-86-0/Glutamic Acid; 72432-10-1/aniracetam; 79-83-4/Pantothenic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Systemic effects of carteolol, a beta-adrenoceptor antagonist in stroke-prone spontaneously hyperten...
Next Document:  trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopa...